CE Holdings (4320) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 May, 2026Executive summary
Achieved record-high revenue and profits for the first half, driven by large-scale EMR projects going live and earlier-than-expected project starts.
Net sales for the six months ended March 31, 2026, rose 18.2% year-over-year to ¥10,877 million, with operating profit up 13.7% to ¥1,399 million and ordinary profit up 14.9% to ¥1,424 million.
Net income attributable to parent company shareholders was ¥708 million, nearly flat year-over-year due to impairment losses from new business ventures.
Financial highlights
Revenue for the first half rose 18.2% year-over-year to ¥10,877 million.
Operating income increased 13.7% to ¥1,399 million; ordinary income up 14.9% to ¥1,424 million.
Gross profit increased to ¥2,578 million from ¥2,284 million year-over-year, with gross margin improvement.
Total assets grew to ¥14,091 million as of March 31, 2026, up from ¥12,746 million at September 30, 2025.
Cash and cash equivalents at period end more than doubled to ¥7,083 million from ¥3,851 million a year earlier.
Outlook and guidance
Full-year revenue forecast raised to ¥16,000 million, up 8.2% from the previous year.
Full-year forecast for FY2026 projects net sales of ¥16,000 million (up 1.1% year-over-year), operating profit of ¥1,600 million (up 13.3%), and profit attributable to owners of parent of ¥870 million (up 12.1%).
Operating income projected at ¥1,600 million (+11.5% YoY), net income at ¥870 million (+16.5% YoY, excluding special factors).
Full-year EPS is forecast at ¥52.21.
Dividend forecast for FY2026 is ¥24 per share at year-end.
Latest events from CE Holdings
- Quarterly profits hit record highs, but full-year outlook signals declines and a lower dividend.4320
Q1 202610 Feb 2026 - Record profit and revenue growth, but next year forecasts a decline in earnings.4320
Q4 202511 Nov 2025 - Revenue up 12% YoY, but profit fell over 20% and net loss posted due to impairments.4320
Q3 20248 Sep 2025 - Record revenue, but net income plunged on one-time losses; strong profit recovery forecast.4320
Q4 20248 Sep 2025 - Record Q1 profit and revenue growth, robust order intake, and higher dividend forecast.4320
Q1 20258 Sep 2025 - Record sales and profit growth, strong outlook, and higher dividends forecast.4320
Q2 20258 Sep 2025 - Record profit and revenue growth, with raised guidance and dividend forecast.4320
Q3 20258 Sep 2025